Back
Eli Lilly & Co. Vs. Regeneron Pharmaceuticals, Inc. Sector Stock Comparison
Buy
76
LLY
Eli Lilly & Co.
Last Price:
$1,063.98
Seasonality Move:
3.31%
Buy
65
REGN
Regeneron Pharmaceuticals, Inc.
Last Price:
$796.18
Seasonality Move:
0.73%
Buy
76
Eli Lilly & Co. (LLY)
is a Buy
Is Eli Lilly & Co. a Buy, Sell or Hold?
-
The current Eli Lilly & Co. [LLY] share price is $1,063.56. The Score for LLY is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
-
LLY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
65
Regeneron Pharmaceuticals, Inc. (REGN)
is a Buy
Is Regeneron Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $796.55. The Score for REGN is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
REGN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LLY Stock Price Chart
What is Eli Lilly & Co.'s stock price today?
-
The Eli Lilly & Co. share price today is $1,063.56The current trend is moderately bullish and LLY is experiencing selling pressure, which indicates risk of future bearish movement.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals, Inc.'s stock price today?
-
The Regeneron Pharmaceuticals, Inc. share price today is $796.55Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.
LLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 17.18 | Buy |
| Relative Strength Index (14 RSI): | 52.59 | Buy |
| Chaikin Money Flow: | -2496474 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1019.08 - 1084.96) | Buy |
| Bollinger Bands (100): | (759.49 - 1035.67) | Buy |
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 19.41 | Buy |
| Relative Strength Index (14 RSI): | 62.58 | Buy |
| Chaikin Money Flow: | -444443 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (730.2 - 789.98) | Buy |
| Bollinger Bands (100): | (569.32 - 739.38) | Buy |
LLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1074.65 | Sell |
| 20-day SMA: | 1065.11 | Sell |
| 50-day SMA: | 1022.71 | Buy |
| 200-day SMA: | 833.7 | Buy |
| 8-day EMA: | 1074.4 | Sell |
| 20-day EMA: | 1062.9 | Buy |
| 50-day EMA: | 1011.6 | Buy |
| 200-day EMA: | 879.47 | Buy |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 783.97 | Buy |
| 20-day SMA: | 771.95 | Buy |
| 50-day SMA: | 730.68 | Buy |
| 200-day SMA: | 607.64 | Buy |
| 8-day EMA: | 788.1 | Buy |
| 20-day EMA: | 771.54 | Buy |
| 50-day EMA: | 729.16 | Buy |
| 200-day EMA: | 668.83 | Buy |
Eli Lilly & Co. Earnings Growth & LLY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.18 per share, and an increase next year of $7.80 per share.
Regeneron Pharmaceuticals, Inc. Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.94 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.11 per share, and an increase next year of $7.84 per share.
Eli Lilly & Co. Technical Analysis
| Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regeneron Pharmaceuticals, Inc. Technical Analysis
| Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||